Last updated 2026-07-27
TL;DR
No online calculator can safely set your dapsone dose. Topical Aczone is applied as a pea-sized amount once daily (5% or 7.5% gel), a fixed dose regardless of weight. Oral dapsone is weight-based (often 1-2 mg/kg/day) and requires G6PD testing first, plus bloodwork monitoring. A prescriber, not a calculator, should set the number.
Is there a real dapsone dosage calculator you can use online?
Not one that's safe to rely on, no. You'll find generic "drug dosage calculator" tools online that plug in weight and spit out a milligram number, but none of them are validated specifically for dapsone, and none of them know your G6PD status, your kidney function, or whether you're on trimethoprim-sulfamethoxazole for something else. That combination matters more than the arithmetic. For topical dapsone (brand name Aczone, 5% or 7.5% gel), there's actually no calculation to do. The FDA label specifies a fixed application: a pea-sized amount spread over the affected area once daily, regardless of your weight or age (down to age 9 for the 7.5% formulation) [1]. Weight-based math simply doesn't apply here. For oral dapsone, dosing genuinely is weight-based, typically expressed as mg/kg/day, and that's exactly why a generic online calculator is risky. The correct starting dose depends on the condition being treated (dermatitis herpetiformis versus leprosy versus off-label dermatologic use), your G6PD enzyme level, and baseline bloodwork. A prescriber calculates this after screening, not before.
What is the standard topical dapsone (Aczone) dose for acne?
The FDA-approved dose for Aczone gel is simple: apply a pea-sized amount to clean, dry skin over the entire acne-affected area once daily [1]. That's it. There's no titration schedule, no weight adjustment, and no mg/kg calculation because the drug works locally in the skin rather than systemically at meaningful blood levels. Aczone comes in two strengths, 5% and 7.5% gel. The 7.5% formulation is approved for once-daily use in patients 9 years and older with acne vulgaris, and clinical trials supporting it showed statistically significant reductions in inflammatory lesions compared to vehicle gel over 12 weeks [1] [1]. The 5% version has a longer track record, approved by the FDA back in 2005 for acne vulgaris in patients 12 and older [2]. A thin layer covering the whole face (or chest, back, wherever the acne is) works better than piling it onto individual pimples. Most people see improvement gradually over 8-12 weeks, not days. If you're wondering whether more product speeds things up: it doesn't, and using more than a pea-sized amount just wastes gel and raises the odds of dryness or peeling.
What is the oral dapsone dosage for approved uses like dermatitis herpetiformis?
For dermatitis herpetiformis, the FDA label for oral dapsone lists an initial adult dose of 50 mg per day, which may be increased up to 300 mg per day or occasionally higher if needed to control the condition, then reduced to the minimum effective dose once symptoms are controlled [3]. This is a systemic drug, so the dose is titrated against your response and your lab values, not set once and forgotten. For leprosy (Hansen's disease), the standard adult regimen from the U.S. National Hansen's Disease Program is dapsone 100 mg daily combined with other antibiotics like rifampin, for a duration measured in months to years depending on the type of leprosy [4]. This is a multi-drug regimen managed by specialists, not a self-directed dose. Pediatric dosing for approved indications is typically weight-based, and the label states dosing should be individualized [3]. None of these numbers are a starting point for someone trying to use oral dapsone off-label for acne. That use isn't FDA-approved, and the systemic risks (covered below) make it a decision for a prescriber weighing real trade-offs, not a dose you look up.
Why does G6PD deficiency matter for dapsone dosing?
Because dapsone causes oxidative stress on red blood cells, and G6PD (glucose-6-phosphate dehydrogenase) is the enzyme that protects those cells from that exact stress. If you're G6PD deficient, a standard oral dapsone dose can trigger hemolytic anemia, sometimes severely. The FDA label states plainly: "Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency may be more prone to hemolytic effects of Dapsone Tablets" [3]. This isn't a rare footnote risk. G6PD deficiency affects an estimated 400 million people worldwide and is common in people with ancestry from Africa, the Mediterranean, and Southeast Asia [5]. Anyone being considered for oral dapsone should be tested for G6PD deficiency before the first dose, not after symptoms appear. Hemolysis on dapsone is dose-related, meaning higher doses in a deficient person cause worse breakdown of red blood cells. This is a core reason oral dapsone is not treated as an interchangeable substitute for topical dapsone. Topical Aczone carries essentially none of this risk because systemic absorption is minimal at approved doses [1], but oral dapsone's entire risk profile depends on getting G6PD status right first. If you're researching Dapsone Rx contraindications, G6PD deficiency sits at the top of that list for the oral form.
What other monitoring does oral dapsone dosing require?
Beyond G6PD testing before starting, oral dapsone needs ongoing bloodwork because it affects red blood cells and white blood cells throughout treatment, more than at the start. The FDA label recommends monitoring complete blood counts weekly for the first month, then monthly for six months, then periodically thereafter [3]. This schedule exists because dapsone can cause methemoglobinemia (a form of oxygen-carrying dysfunction in blood), agranulocytosis (a dangerous drop in infection-fighting white blood cells), and dapsone hypersensitivity syndrome, a rare but serious reaction that can include fever, rash, and organ involvement, typically appearing 2-6 weeks after starting the drug [3] . Dapsone hypersensitivity syndrome carries a reported mortality rate in the range of 9.9%, based on case series data, which is a big number for what many people assume is a routine antibiotic . This is exactly why oral dapsone dosing isn't something to self-calculate or adjust based on how you feel. The dose, the monitoring interval, and the decision to continue or stop all depend on lab values a prescriber is tracking, and this is the core reason oral dapsone for acne (an off-label use) gets far more caution from dermatologists than topical Aczone.
How is topical dapsone dosing different from oral dapsone dosing?
| FDA-approved use | Acne vulgaris [1] [2] | Dermatitis herpetiformis, leprosy [3] [4] | |
|---|---|---|---|
| Typical dose | Pea-sized amount, once daily, fixed | 50-300 mg/day, weight/response-based [3] | |
| G6PD testing required? | Not required by label | Yes, before starting [3] | |
| Main risks | Local dryness, mild peeling, rare methemoglobinemia at high body surface use | Hemolysis, methemoglobinemia, agranulocytosis, hypersensitivity syndrome [3] | |
| Monitoring | None routine | CBC weekly x4, then monthly x6, then periodic [3] | |
| Use for acne | FDA-approved | Off-label, not standard of care | If someone tells you they're taking "dapsone for acne," ask which form. If it's oral, that's an off-label use carrying real systemic risk that a topical prescription doesn't carry, and it deserves the G6PD conversation before anything else. |
The difference isn't a matter of degree, it's a difference in kind. Topical Aczone is a fixed, low-absorption local treatment. Oral dapsone is a systemic sulfone antibiotic with real hematologic risk. Conflating the two is the single most dangerous mistake in dapsone research. | Feature | Topical dapsone (Aczone 5%/7.5%) | Oral dapsone |
Can you adjust your own dapsone dose if it's not working?
For topical Aczone: no adjustment is needed or recommended. Using more than a pea-sized amount doesn't clear acne faster, based on how the FDA trials were designed and dosed [1] [1]. If 12 weeks pass with no improvement, that's a conversation with a prescriber about switching or adding another topical, not doubling your own dose. For oral dapsone: absolutely not on your own. Dose changes affect hemolysis risk and methemoglobin levels directly, and titration is done based on lab results and clinical response, tracked by the prescriber managing your bloodwork [3]. Self-adjusting an oral dapsone dose without monitoring is how people end up in the emergency room with unexplained fatigue, shortness of breath, or a bluish tint to their skin, all signs of methemoglobinemia.
Does dapsone dosing change based on age or weight?
For topical Aczone, age matters for eligibility (7.5% gel is approved from age 9, 5% gel from age 12) but not for the amount applied [1] [2]. A 14-year-old and a 40-year-old use the same pea-sized amount. For oral dapsone, weight matters directly because dosing is typically calculated in mg/kg/day for pediatric use, and adult dosing is titrated by response rather than strict weight-based formula in most labeled uses [3]. Kidney or liver impairment can also change how the drug is cleared, which is another reason a generic calculator that only asks for weight and age is incomplete. It doesn't ask about renal function, it doesn't ask about G6PD status, and it doesn't know your baseline hemoglobin.
What happens if you take too much oral dapsone?
Overdose symptoms typically involve the same mechanisms as standard toxicity, just more severe: methemoglobinemia causing cyanosis (bluish skin) and shortness of breath, hemolytic anemia, and in severe cases, seizures or cardiac effects [3]. The FDA label notes methylene blue is used as a treatment for severe methemoglobinemia in dapsone toxicity, though it should be used cautiously in G6PD-deficient patients since methylene blue itself can worsen hemolysis in that population [3]. This is another layer of why G6PD testing isn't a box-checking exercise. It changes more than whether you should start dapsone, and how an overdose or adverse reaction would even be treated. If you suspect an oral dapsone overdose, that's an emergency room visit, not a wait-and-see situation.
How does dapsone half-life affect dosing frequency?
Oral dapsone has a reported elimination half-life in the range of about 20-30 hours in most adults, which is part of why it's typically dosed once daily rather than multiple times a day [3]. A longer half-life means the drug (and its metabolites, some of which also carry oxidative activity) stays in the system for days after a dose, which is relevant to how long side effects like hemolysis can persist after adjustment or discontinuation. For a full breakdown of how this timing works and what it means for missed doses or drug interactions, see Dapsone Rx half life. Topical Aczone, by contrast, has minimal systemic absorption at approved doses, so half-life is far less clinically relevant for the topical form [1].
Where does a provider-reviewed dosing approach fit in?
Because dapsone dosing (especially oral) depends on lab values that change over time, the safest path is a prescriber who orders G6PD testing, sets an initial dose based on the approved indication, and adjusts based on follow-up bloodwork. Dapsone Rx works as a provider-reviewed resource pointing people toward that process rather than a self-dosing shortcut, and any prescription that results is filled through a licensed pharmacy partner, not compounded or dispensed by Dapsone Rx itself. If you're asking about dosing because you're already prescribed dapsone and want to understand injection technique (relevant for some compounded or specialty formulations), see Dapsone Rx how to inject and Dapsone Rx injection sites. If your question is about storage rather than dose, check Dapsone Rx storage and shelf life and does Dapsone Rx need to be refrigerated.
What questions should you ask a prescriber before starting dapsone?
Ask which form is being prescribed, topical or oral, and why. Ask whether G6PD testing has been done if oral dapsone is on the table, and what the result was. Ask what the monitoring schedule looks like (the FDA label suggests weekly CBCs for the first month on oral dapsone, tapering to monthly and then periodic checks) [3]. Ask what symptoms should prompt an immediate call: unusual fatigue, shortness of breath, fever, rash, or a bluish tint to lips or fingertips are all reasons to stop and call rather than wait for the next scheduled lab draw. For topical Aczone, the relevant questions are simpler: how long before you should expect to see change (typically 8-12 weeks based on trial data) [1], and what to do about dryness or peeling if it happens early on.
Frequently asked questions
Is there an official dapsone dosage calculator?
No. Topical Aczone uses a fixed pea-sized dose regardless of weight, so no calculator applies. Oral dapsone dosing is weight- and response-based but requires G6PD testing and prescriber-managed titration, which no online calculator can safely replicate. Any tool that gives you an oral dapsone dose without asking about G6PD status should not be trusted.
What is the standard dose of Aczone gel for acne?
A pea-sized amount applied once daily to the entire acne-affected area, per the FDA label for both the 5% and 7.5% formulations [1]. There's no weight-based adjustment. Using more than a pea-sized amount doesn't improve results faster and may increase dryness or peeling.
How much oral dapsone is used for dermatitis herpetiformis?
The FDA label lists an initial adult dose of 50 mg/day, which can be increased up to 300 mg/day (occasionally higher) to control symptoms, then reduced to the lowest effective maintenance dose [4]. Dosing is individualized and requires ongoing monitoring, not a fixed regimen you set yourself.
Why do you need a G6PD test before taking oral dapsone?
Because G6PD-deficient red blood cells lack protection against the oxidative stress dapsone causes, and taking the drug without knowing your status can trigger hemolytic anemia. The FDA label states G6PD-deficient patients "may be more prone to hemolytic effects of Dapsone Tablets" [4]. Testing before the first dose is standard practice, not optional.
Can you use oral dapsone for acne instead of topical Aczone?
Oral dapsone is not FDA-approved for acne; it's approved for dermatitis herpetiformis and leprosy [4][5]. Some prescribers use it off-label for severe acne, but that requires G6PD testing and ongoing bloodwork given the hemolysis and agranulocytosis risks. Topical Aczone is the FDA-approved, lower-risk option most people researching dapsone for acne actually mean.
What blood tests are needed while on oral dapsone?
The FDA label recommends complete blood count monitoring weekly for the first month, then monthly for six months, then periodically after that [4]. This checks for hemolytic anemia, methemoglobinemia, and agranulocytosis, all dose-related risks that require lab tracking rather than symptom-watching alone.
What is dapsone hypersensitivity syndrome?
A rare but serious reaction to oral dapsone involving fever, rash, and potential organ involvement, typically appearing 2-6 weeks after starting the drug. Case series report a mortality rate around 9.9% for this syndrome [7]. It's a key reason oral dapsone requires close medical supervision and isn't a casual acne treatment.
Does topical dapsone require G6PD testing?
No. The FDA label for Aczone does not require G6PD screening because systemic absorption is minimal at approved topical doses [1]. G6PD testing is specifically a requirement tied to oral dapsone, where the drug reaches levels in the bloodstream capable of causing hemolysis in deficient individuals.
How long does it take for Aczone to work on acne?
Clinical trial data behind the FDA approval showed measurable reductions in inflammatory lesions over a 12-week period compared to vehicle gel [2]. Most people should expect gradual improvement over 8-12 weeks rather than a quick fix, and continuing daily use matters more than the amount applied.
Can children use dapsone, and does the dose change?
Aczone 7.5% gel is approved for acne in patients 9 years and older, and the 5% gel for 12 years and older, both at the same fixed pea-sized application regardless of age within those ranges [1][3]. Oral dapsone pediatric dosing for approved conditions is typically weight-based and individualized under specialist care [4].
What happens if you take too much oral dapsone?
Overdose can cause methemoglobinemia (bluish skin, shortness of breath) and severe hemolytic anemia, per the FDA label, with methylene blue used cautiously as a treatment for severe cases [4]. This is an emergency situation requiring immediate medical care, not something to manage at home.
Is dapsone dosing the same for leprosy as for dermatitis herpetiformis?
No. The U.S. National Hansen's Disease Program protocol for leprosy uses dapsone 100 mg daily combined with other antibiotics like rifampin for months to years [5], while dermatitis herpetiformis dosing starts lower (50 mg/day) and titrates up to control symptoms [4]. Both require specialist management, not self-directed dosing.
Why can't a generic online dosage calculator be used for dapsone?
Because oral dapsone dosing safety depends on G6PD status, kidney and liver function, and baseline blood counts, none of which a generic weight-and-age calculator asks about. The FDA label ties dosing decisions to lab monitoring, not a fixed formula, making a standalone calculator inherently incomplete for this drug [4].
Sources
- FDA, Aczone (dapsone) gel 7.5% prescribing information: Aczone dosing is a pea-sized amount applied once daily; 7.5% approved from age 9
- FDA, original Aczone (dapsone) gel 5% approval: Aczone 5% gel approved in 2005 for acne vulgaris in patients 12 and older
- HRSA National Hansen's Disease Program, recommended treatment regimens: Standard leprosy regimen uses dapsone 100 mg daily combined with rifampin
- CDC, G6PD deficiency fact sheet: G6PD deficiency affects an estimated hundreds of millions of people worldwide and varies by ancestry
- National Institutes of Health, StatPearls: Dapsone Hypersensitivity Syndrome: Dapsone hypersensitivity syndrome mortality rate and typical onset window of 2-6 weeks